Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GUSB pseudogene 6 (GUSBP6) is a human pseudogene, which means it is a segment of DNA that resembles the sequence of a functional gene (here, the glucuronidase beta gene, GUSB) but does not encode a functional protein.[5] GUSBP6 has no known protein product, no confirmed biological activity, and is not considered a therapeutic target. Pseudogenes in general may sometimes modulate gene expression at the RNA level through various mechanisms (such as acting as non-coding RNAs, miRNA decoys, or competitive endogenous RNAs), but there is no specific evidence or literature documenting any regulatory, disease-related, or biomarker function for GUSBP6 specifically.[5][2][9] It should not be confused with the canonical GUSB gene, which encodes lysosomal beta-glucuronidase, an important hydrolase enzyme involved in glycosaminoglycan degradation; GUSBP6 is only related in sequence and has no known function.[1][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GUSB pseudogene 6 (GUSBP6).